SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Novo Nordisk Seeks FDA and EMA Approval for Etavopivat

Novo Nordisk said it submitted applications to the FDA and EMA for etavopivat, an investigational once-daily oral treatment for adolescents and…

NOVOB

Related stories